Skip to main content
. 2021 Mar 26;16:2443–2459. doi: 10.2147/IJN.S289228

Figure 8.

Figure 8

(A) In vivo imaging of tumor-bearing mice after administration of Cy7-modified nanoparticles at 1, 2, 4, 6, 8, and 12 h. (B) Ex vivo fluorescence images of tissues including heart, liver, spleen, lung, kidney, brain, and tumor collected at 12 h post-injection of (i) Cy7-BSA-NPs and (ii) cetuximab-vc-DOX-Cy7-BSA-NPs.